25 March 2015 - Deborah Wilkes
Archived
Opportunities to acquire leading OTC players have generally been few and far between over the past 20 years. But that all changed in 2014, when Novartis’ OTC business, Merck & Co’s Consumer Care business and Belgian OTC specialist Omega Pharma came up for grabs.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.